High-grade dysplasia and intramucosal adenocarcinoma are premalignant and malignant
lesions of the esophagus. The incidence of lymphatic or systemic metastases is low and …

The clinical value of endoscopic ablation of nondysplastic Barrett's epithelium is
controversial. It has been stated that ablation, combined with acid suppression or antireflux …

Oesophageal adenocarcinoma is rapidly increasing in Western countries. This tumour
frequently presents late in its course with metastatic disease and has a very poor prognosis …

Background and study aims: It has been postulated that the endoscopic ablation of Barrett's
esophagus can lead to complete eradication of the disease. This study was undertaken to …

Low-grade dysplasia in Barrett esophagus remains an ongoing challenge in clinical
management. Recent studies suggest an increased risk in progression of low-grade …

Barrett's Esophagus is a common condition associated with chronic gastroesophageal reflux
disease. It is well known that it has an association with a higher incidence of esophageal …

Barrett's esophagus is a prevalent, premalignant condition affecting the gastroesophageal
junction and distal esophagus. Ablation plus antireflux therapy has recently been advocated …

Barrett's esophagus has traditionally been considered to be a predominantly 'Western
world'neoplastic condition. However, over the years, Asian countries are beginning to …

The excellent efficacy, side-effect profile, and cost-effectiveness appear to make RFA the
intervention of choice in cases of high-grade dysplasia. RFA for low-grade dysplasia may be …

The management of Barrett's oesophagus should aim to treat symptoms, and prevent
complications of reflux. Treatment of choice is a proton pump inhibitor, with the option of …